论文部分内容阅读
目的:观察多索茶碱治疗支气管哮喘的临床疗效,指导临床用药。方法:采取随机分组的原则,共收集110例支气管哮喘患者分为两组,其中治疗组55例;对照组55例。治疗组予以多索茶碱治疗。7天后观察两组患者临床症状、体征、实验室检查等指标评价近期临床疗效。结果:治疗组与对照组具有统计学意义差异(P<0.05),有效率分布为92.2%和75.5%。并且多索茶碱的不良反应明显低于氨茶碱(P<0.05),具有统计学意义。结论:支气管哮喘的患者可以优先考虑多索茶碱治疗,其具有确切的疗效,而且不良反应较低。
Objective: To observe the clinical efficacy of doxofylline in the treatment of bronchial asthma and guide the clinical medication. Methods: According to the principle of randomization, a total of 110 patients with bronchial asthma were collected and divided into two groups, 55 in the treatment group and 55 in the control group. The treatment group was treated with doxofylline. Seven days later, two groups of patients were observed clinical symptoms, signs, laboratory tests and other indicators to evaluate the recent clinical efficacy. Results: The difference between the treatment group and the control group was statistically significant (P <0.05). The effective rates were 92.2% and 75.5%. And the adverse reaction of doxofylline was significantly lower than aminophylline (P <0.05), with statistical significance. CONCLUSIONS: Patients with bronchial asthma can prioritize doxofylline therapy with definite efficacy and lower adverse reactions.